课题基金 / 基金详情

Cell Growth Control by Regulating the Expression of p73 : the Basics and Development of New Clinical Applications

Cell Growth Control by Regulating the Expression of p73 : the Basics and Development of New Clinical Applications
通过调节 p73 表达来控制细胞生长:新临床应用的基础知识和开发
批准号:
13670182
负责人:
ICHIMIYA Shingo
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003

项目摘要

项目成果

ICHIMIYA Shingo的其他基金

相似基金

相关文献

中文摘要
翻译
越来越多的证据表明,编码p73的基因是一种与原型抑癌基因p53同源的分子,它知道在各种人类恶性肿瘤中不同于p53的罕见突变。结合p73和p53的功能相似性,我们假设当肿瘤细胞的内在p73可以通过迄今未知的机制上调时,肿瘤细胞的生长可能受到控制。为了阐明这一机制,我们新制造了针对p73的抗体,并对一系列人体组织进行了分析。结果表明,p73仅定位于胸腺髓质上皮细胞的胞核,而不定位于皮质上皮细胞。此外,使用胸腺上皮细胞系进行的体外研究表明,p73可能参与了M-CSF和GM-CSF的调节。众所周知,在髓上皮细胞中培养树突状细胞和巨噬细胞,以建立该区域未成熟T细胞的负选择。因此,这些提示延髓中的p73可能具有控制基质细胞进行负选择的重要作用。我们还与我校海洋生物科学研究所合作,研究了一种特定调控自然资源中生物活性分子p73表达的分子。目前,我们已经发现了A的某一小部分。海胆具有上调人类胸腺上皮细胞p73的能力。我们希望进一步阐明p73的表达机制,并发展其相关的方法学,可能通过激活抗原提呈细胞来控制肿瘤细胞周期和肿瘤免疫。
英文摘要
Accumulating evidence has demonstrated that the gene encoding p73, a molecule homologous to the archetypal tumor suppressor p53, knows infrequent mutation in various human malignancies unlike p53. Together with functional similarities of p73 to p53, we hypothesized that tumor cell growth might be controlled when an intrinsic p73 of tumor cells could be up-regulated by hitherto unknown mechanism. To elucidate the mechanism, we have newly made antibodies specific to p73 and analyzed a series of human tissues. Results indicated that p73 was specifically localized at the nuclei of thymic medullary epithelial cells, but not in cortical epithelium. Moreover, in vitro studies using thymic epithelial cell lines showed that p73 was potentially involved regulation of M-CSF as well as GM-CSF. It is well known that in medullary epithelium foster dendritic cells and macrophages for establishing negative selection of immature T cells in the region. Thus, these imply that p73 in the medulla might have important roles, to control stromal cells for negative selection. We also investigated a. molecule specifically regulating the expression of p73 from biologically active molecules of natural resources in collaboration with the Institute of Marine Bioscience of our university. Currently, we have found a. certain fraction of the Aristertoles of. sea urchin has a capacity to up-regulating p73 of human thymic epithelial cells. We would like to further clarify the expression mechanism of p73 and develop its related methodology for controlling tumor cell cycle as well as tumor immunity possibly through the activation of antigen presenting cells.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
Momota H, Ichimiya S, Ikeda T, et al.: "Immunohistochemical analysis of the p53 family members in human craniopharyngiomas"Brain Tumor Pathology. 20. 311-315 (2003)
Momota H、Ichimiya S、Ikeda T 等人:“人颅咽管瘤中 p53 家族成员的免疫组织化学分析”脑肿瘤病理学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Momota H, Ichimiya S, Kondo N, et al.: "Histone H2AX sensitizes glioma cells to genotoxic stimuli by recruiting DNA double-strand break repair proteins"International Journal of Oncology. 23・2. 311-315 (2003)
Momota H、Ichimiya S、Kondo N 等人:“组蛋白 H2AX 通过招募 DNA 双链断裂修复蛋白使神经胶质瘤细胞敏感”,《国际肿瘤学杂志》23・2(2003 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ichimiya S, Kojima T, Momota H, et al.: "p73 is expressed in human thymic epithelial cells"Journal of Histochemistry and Cytochemistry. 50. 455-462 (2002)
Ichimiya S、Kojima T、Momota H 等人:“p73 在人胸腺上皮细胞中表达”Journal of Histochemistry and Cytochemistry。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ichimiya S, Kojima T, Momota H, et al.: "p73 is expressed in human thymic epithelial cells."Journal of Histochemistry and Cytochemistry. 50. 455-462 (2002)
Ichimiya S、Kojima T、Momota H 等人:“p73 在人胸腺上皮细胞中表达。”组织化学和细胞化学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
30
    Analysis of antibody production program underlying immune-related disorders of human system
    • 批准号:
      23590405
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      ICHIMIYA Shingo
    • 依托单位:
    Novel role of ALOX5 (L22) in the control of antibody production
    • 批准号:
      20590347
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2008
    • 负责人:
      ICHIMIYA Shingo
    • 依托单位:
    国内基金
    海外基金
    Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
    基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
    • 批准号:
      2026JJ82384
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      颜志鹏
    • 依托单位:
    APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
    • 批准号:
      JCZRQNB202600696
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究